The evaluation of vitamin D status in normocalcemic primary hyperparathyroidism

被引：1
|
作者：
Saliba, Walid [1 ,2 ,4 ]
Lavi, Idit [1 ,2 ]
Rennert, Gad [1 ,2 ,3 ]
机构：
[1] Technion Israel Inst Technol, Carmel Med Ctr, Dept Community Med & Epidemiol, Clalit Hlth Serv, IL-34362 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-34362 Haifa, Israel
[3] Clalit Hlth Serv Headquarters, Off Chief Phys, Dept Epidemiol & Dis Prevent, Tel Aviv, Israel
[4] Haemek Med Ctr, Dept Internal Med C, Afula, Israel
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2013年 / 24卷 / 01期
关键词：
Vitamin D; 25(OH)D; PTH; Primary hyperparathyroidism; Normocalcemic primary hyperparathyroidism; 3RD INTERNATIONAL WORKSHOP; DIAGNOSIS;
D O I：
10.1016/j.ejim.2012.05.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E8 / E8
页数：1
相关论文
共 50 条
  • [31] Normocalcemic and Normohormonal Primary Hyperparathyroidism: Laboratory Values and End-Organ Effects
    Hollowoa, Blake R.
    Spencer, Horace J., III
    Stack, Brendan C., Jr.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 165 (03) : 387 - 397
  • [32] Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
    Shacham, Elena Chertok
    Maman, Nimra
    Lazareva, Tatyana
    Masalha, Refaat
    Mahagna, Lila
    Sela, Gala
    Ishay, Avraham
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism
    Baugh, Katherine A.
    McCoy, Kelly L.
    Leung, Janet H.
    Carty, Sally E.
    Ramonell, Kimberly M.
    Yip, Linwah
    SURGERY, 2024, 175 (01) : 166 - 171
  • [34] Vitamin D deficiency and primary hyperparathyroidism
    Silverberg, Shonni J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : V100 - V104
  • [35] Primary Hyperparathyroidism, Hypoparathyroidism and Vitamin D
    Cardoso, Luis
    Ferreira, Mafalda Martins
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2023, 18 : 57 - 59
  • [36] Vitamin D Treatment in Primary Hyperparathyroidism
    Rolighed, Lars
    Bollerslev, Jens
    Mosekilde, Leif
    CURRENT DRUG SAFETY, 2011, 6 (02) : 100 - 107
  • [37] Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy
    Vignali, E.
    Cetani, F.
    Chiavistelli, S.
    Meola, A.
    Saponaro, F.
    Centoni, R.
    Cianferotti, L.
    Marcocci, C.
    ENDOCRINE CONNECTIONS, 2015, 4 (03): : 172 - 178
  • [38] Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations
    Barale, Marco
    Maiorino, Federica
    Pusterla, Alessia
    Fraire, Federica
    Sauro, Lorenzo
    Presti, Michela
    Sagone, Noemi
    Ghigo, Ezio
    Arvat, Emanuela
    Procopio, Massimo
    ENDOCRINE, 2024, 86 (03) : 1140 - 1147
  • [39] Clinical Significance of Vitamin D Deficiency in Primary Hyperparathyroidism, and Safety of Vitamin D Therapy
    Mikhail, Nasser
    SOUTHERN MEDICAL JOURNAL, 2011, 104 (01) : 29 - 33
  • [40] Parathyroid sonography in patients with normocalcemic primary hyperparathyroidism
    Ishay, Avraham
    Chervinsky, Leonid
    Luboshitzky, Rafael
    ENDOCRINOLOGIST, 2008, 18 (03): : 130 - 133
12345